SCHEMBL2812164

SCHEMBL2812164

CC(=CSc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.43
AKR1C3 P42330 2/20 0.43
CYP2C19 P33261 2/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 3/20 0.42
ALDH1A1 P00352 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 4/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 2/20 0.37
S100A4 P26447 1/20 0.36
SDCBP O00560 1/20 0.36
SDC2 P34741 1/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812162 1.00 CYP2C9 (0.43) CYP2C9AKR1C3CYP2C19AKR1C2AKR1C1
SCHEMBL2808655 0.83 ALDH1A1 (0.47) AKR1C3MAPTALDH1A1NPSR1LMNA
SCHEMBL2808652 0.83 ALDH1A1 (0.47) AKR1C3MAPTALDH1A1NPSR1LMNA
SCHEMBL2812008 0.82 AKR1C3 (0.50) CYP2C9AKR1C3HSD17B10MAPTALDH1A1
SCHEMBL2812007 0.82 AKR1C3 (0.50) CYP2C9AKR1C3HSD17B10MAPTALDH1A1
SCHEMBL2808943 0.81 AKR1C3 (0.37) CYP2C9AKR1C3CYP2C19MAPTALDH1A1
SCHEMBL2808944 0.81 AKR1C3 (0.37) CYP2C9AKR1C3CYP2C19MAPTALDH1A1
SCHEMBL12851391 0.81 MAPT (0.40) CYP2C9CYP2C19HSD17B10MAPTALDH1A1
SCHEMBL2809174 0.78 RAB9A (0.47) CYP2C9CYP2C19HSD17B10MAPTALDH1A1
SCHEMBL2809170 0.78 RAB9A (0.47) CYP2C9CYP2C19HSD17B10MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 CYP2C9 313/4885AKR1C3 18/4885CYP2C19 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.